Caplin Point Laboratories Ltd

524742

Summary

Fair Value Assessment
Overvalued (13% Premium)
Fair ValueQ1,775.39UncertaintyHigh
Close Price2,022.75Jun 23, 2025
Market Closed
2,022.75
Price Down by 25.45 | 1.24 %
Previous Close
2,022.75
Day Range
2,010.00 – 2,054.35
Year Range
1,370.00 – 2,636.00
Bid / Ask
Market Cap
153.8 Bil
Volume / Average
7.4 k / 8.5 k
Beta (5-Year)
Shares Outstanding
76.01 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, injections (liquid and lyophilized, prefilled syringes), ophthalmic solutions, liquid orals, soft gel capsules, ointments, creams, gels, powders for injections, suppositories, ovules, pre-mix bag formulations, inhalers, sprays, and IV infusions. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops.
Contact
Ashvich Tower, Developed Plots Industrial Estate No. 3, 3rd Floor, Chennai, TN 600 096
T +91 4424968000
www.caplinpoint.net opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Mar 31, 2025
Fiscal Year End
Mar 31, 2025
Employees
4,882

Key Metrics

Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Income Statement (in Bil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Revenue
19.37 19.37 16.77 14.67 12.63 10.48
Revenue Growth %
14.37% 14.37% 15.34% 15.54% 20.49% 24.12%
Gross Profit
11.67 11.67 9.47 8.04 7.03 5.73
Gross Profit Margin %
60.21% 60.21% 56.50% 54.78% 55.63% 54.68%
Operating Income
5.81 5.81 5.01 3.96 3.50 2.93
Operating Margin %
29.99% 29.99% 29.87% 27.00% 27.68% 27.98%
EBIT
6.77 6.77 5.18 4.52 3.63 2.97
EBIT Margin %
34.96% 34.96% 30.89% 30.83% 28.74% 28.29%
EBITDA
7.43 7.43 5.71 4.97 4.10 3.34
EBITDA Margin %
38.37% 38.37% 34.08% 33.89% 32.46% 31.82%
Net Income
5.36 5.36 4.57 3.76 3.00 2.42
Net Profit Margin %
27.93% 27.93% 27.52% 25.70% 24.42% 23.99%
Basic EPS
70.57 70.57 60.19 49.62 39.61 32.03
Diluted EPS
70.25 70.25 59.90 49.18 39.26 31.71
Normalized EPS
70.70 70.70 59.68 49.67 39.94 32.20
Total Dividends per Share
5.00 5.00 4.50 4.00 3.00 0.40
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Balance Sheet (in Bil, except ratios)
03/31/2025
03/2025
03/2024
03/2023
03/2022
03/2021
Total Assets
32.09 32.09 26.98 21.91 17.36 13.64
Total Liabilities
3.23 3.23 3.51 2.84 2.26 1.60
Total Debt
0.05 0.05 0.02 0.05 0.02 0.18
Total Equity
28.86 28.86 23.47 19.07 15.10 12.03
Cash And Cash Equivalents
1.99 1.99 5.50 1.78 4.57 4.57
Working Capital
18.28 18.28 15.62 12.86 10.90 8.93
Shares Outstanding (Mil)
75.94 75.90 75.89
Book Value Per Share
375.01 375.01 284.36 247.75 175.88 125.99
Total Debt To Equity
0.00 0.00 0.00 0.00 0.00 0.02
Key-Metrics - Financial Summary shows the income statement, balance sheet , cash flow statement data - 5 year and 10 year of the company stock.
Cash Flow Statement (in Bil, except ratios)
03/31/2025
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
4.32 3.18 2.72 3.37 2.66 0.45
Cash From Investing Activities
-3.35 -3.20 -2.18 -2.71 -0.05 -0.55
Cash From Financing Activities
-0.38 -0.38 -0.28 -0.41 -0.24 0.80
Capital Expenditures
1.92 1.46 1.94 0.91 0.70 0.77
Free Cash Flow
3.60 3.11 1.80 2.57 1.91 1.60
Change in Cash
0.59 -0.40 0.26 0.25 2.36 0.70

Profile

Executives shows executive data in a table format includes information on Key Executives, Board of Directors.
Name (Age)
5-Year Trend
2021
2022
2023
2024
2025
Sridhar Ganesan (—) Director and Managing Director
Total Compensation for all Key Executives
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
Oops!
Something went wrong.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
Oops!
Something went wrong.

Ownership

Ownership lists the Fund owners and Intitutional owners of the stock.
Name
Morningstar
Rating
% Total
Shares Held
% Total
Assets
Trend
Prev. 8 Qtrs
Current Shares
Change Amount
Change %
Date
Principal Glb Emerging Markets R5 0.75 0.53 570,528
41,348
7.81%
May 31, 2025
PineBridge India Equity Composite Not Rated 0.70 1.81 534,546
-73,454
12.08%
Mar 31, 2025
PineBridge India Equity Y 0.70 1.74 534,546
0
0.00%
Feb 28, 2025
UTI Small Cap Reg Gr 0.46 1.67 350,500
0
0.00%
May 31, 2025
Vanguard Total Intl Stock Index Inv 0.41 0.00 309,175
0
0.00%
May 31, 2025
Total (for Top 5) 3.02 2,299,295
-32,106

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top